<DOC>
	<DOCNO>NCT00196391</DOCNO>
	<brief_summary>This multicenter trial compare effectiveness 4 dose DR-2021 placebo oral micronized progesterone induce withdrawal bleed woman secondary amenorrhea .</brief_summary>
	<brief_title>A Trial Evaluate DR-2021 Women With Secondary Amenorrhea</brief_title>
	<detailed_description>In multicenter trial patient randomize receive DR-2021 , oral micronized progesterone , placebo evaluate effect withdrawal bleed woman secondary amenorrhea . Patients treat 10 day study participation approximately 24 day . Patients undergo physical exam include pelvic breast exam . Patients require complete bleed spot information daily diary .</detailed_description>
	<mesh_term>Amenorrhea</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>Not pregnant Secondary amenorrhea oligomenorrhea least 50 day duration Not currently hormonal medication Not risk pregnancy willing use nonhormonal method birth control study ( ie , condom ) Use injectable implantable estrogen , progestin , androgen within last 6 month Use hormonal birth control within last 3 month Any contraindication use progestin</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>secondary amenorrhea</keyword>
	<keyword>progesterone</keyword>
</DOC>